Top

Published in:

01-10-2011 | Original Article

Higher DHEA-S (dehydroepiandrosterone sulfate) levels are associated with depressive symptoms during the menopausal transition: results from the PENN Ovarian Aging Study

Authors: Mary Frances Morrison, Ellen W. Freeman, Hui Lin, Mary D. Sammel

Published in: Archives of Women's Mental Health | Issue 5/2011

Abstract

The influence of sex hormones on mood during the menopausal transition has been the subject of ongoing investigation. Because dehydroepiandrosterone sulfate (DHEA-S) has been associated with several indicators of healthy aging, we conducted a population-based study of midlife women to determine the relationship between DHEA-S levels and depressive symptoms and major depression during the transition through menopause. Unexpectedly, the original report revealed a positive correlation between DHEA-S levels and depressive symptoms at baseline. The cohort was studied over 11 years to determine whether the positive association between DHEA-S levels and depression persists through the menopausal transition. We conducted a longitudinal cohort study with 11 assessments during an 11-year interval in Philadelphia, Pennsylvania, using a randomly identified, population-based sample of 436 African American and Caucasian premenopausal women aged 35 to 47 years at enrollment. For outcome measures, we used the Center for Epidemiologic Studies Depression Scale and standardized diagnosis of major depression. In a multivariable model, DHEA-S levels were positively associated with depressive symptoms when adjusted for age, menopausal stage, race, smoking status, and body mass index. There was no association between DHEA-S levels and a diagnosis of major depression. DHEA-S levels were positively associated with depressive symptoms through the menopausal transition. No association with major depression was apparent during the menopausal transition, but results may have limited power due to low prevalence of major depression in this cohort. These findings suggest that taking DHEA supplements may increase depressive symptoms for some women, and women and their physicians should be cautious about instituting DHEA replacement therapy during the menopausal transition.

Assies J, Visser I, Nicolson NA, Eggelte TA, Wekking EM, Huyser J et al (2004) Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings. Psychiatry Res 128(2):117–122PubMedCrossRef

Barrett-Connor E, von Mühlen D, Laughlin GA, Kripke A (1999) Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo study. J Am Geriatr Soc 47(6):685–691PubMed

Bromberger JT, Schott LL, Kravitz HM, Sowers M, Avis NE, Gold EB et al (2010) Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the study of women's health across the nation (SWAN). Arch Gen Psychiatry 67(6):598–607PubMedCrossRef

Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL (2000) A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85(8):2832–2838PubMedCrossRef

Carlström K, Karlsson R, Von Schoultz B (2002) Diurnal rhythm and effects of oral contraceptives on serum dehydroepiandrosterone sulfate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretion. Scand J Clin Lab Investig 62(5):361–368CrossRef

Casson PR, Toth MJ, Johnson JV, Stanczyk FZ, Casey CL, Dixon ME (2010) Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab 95(9):4276–4282PubMedCrossRef

Crawford S, Santoro N, Laughlin GA, Sowers MF, McConnell D, Sutton-Tyrrell K et al (2009) Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab 94(8):2945–2951PubMedCrossRef

Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H (2002) Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 77(Suppl 4):S42–S48PubMedCrossRef

Fabian TJ, Dew MA, Pollock BG, Reynolds CF III, Mulsant BH, Butters MA et al (2001) Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biol Psychiatry 50(10):767–774PubMedCrossRef

Freeman EW, Sammel MD, Gracia CR, Kapoor S, Lin H, Liu L et al (2005) Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril 83(2):383–392PubMedCrossRef

Fukai S, Akishita M, Yamada S, Hama T, Ogawa S, Iijima K et al (2009) Association of plasma sex hormone levels with functional decline in elderly men and women. Geriatr Gerontol Int 9(3):282–289PubMedCrossRef

Girgis R, Abrams SA, Castracane VD, Gunn SK, Ellis KJ, Copeland KC (2000) Ethnic differences in androgens, IGF-I and body fat in healthy prepubertal girls. J Pediatr Endocrinol 13(5):497–503CrossRef

Goldman N, Glei DA (2007) Sex differences in the relationship between DHEAS and health. Exp Gerontol 42(10):979–987PubMedCrossRef

Gracia CR, Sammel MD, Freeman EW, Lin H, Langan E, Kapoor S et al (2005) Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause 12(2):128–135PubMedCrossRef

Gurland BJ (2004) Epidemiology of psychiatric disorders. In: Sadavoy J, Jarvik LF, Grossberg GT, Meyers BS (eds) Comprehensive textbook of geriatric psychiatry, 3rd edn. Norton, New York, pp 3–25

Haren MT, Malmstrom TK, Banks WA, Patrick P, Miller DK, Morley JE (2007) Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. Maturitas 57(4):347–360PubMedCrossRef

Harsh V, Meltzer-Brody S, Rubinow DR, Schmidt PJ (2009) Reproductive aging, sex steroids, and mood disorders. Harv Rev Psychiatry 17(2):87–102PubMedCrossRef

Johannes CB, Stellato RK, Feldman HA, Longcope C, McKinlay JB (1999) Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women’s health study. J Clin Epidemiol 52(2):95–103PubMedCrossRef

Johansson T, Le Grevès P (2005) The effect of dehydroepiandrosterone sulfate and allopregnanolone sulfate on the binding of [3H]ifenprodil to the N-methyl-d-aspartate receptor in rat frontal cortex membrane. J Steroid Biochem Mol Biol 94(1–3):263–266PubMedCrossRef

Khaw KT, Tazuke S, Barrett-Connor E (1988) Cigarette smoking and levels of adrenal androgens in postmenopausal women. New Engl J Med 318:1705–1709PubMedCrossRef

Lasley BL, Santoro N, Randolf JF, Gold EB, Crawford S, Weiss G et al (2002) The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 87(8):3760–3767PubMedCrossRef

Maeng S, Zarate CA (2007) The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9(6):467–474PubMedCrossRef

Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138:923–936PubMed

Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH (2009) Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 30(1):65–91PubMedCrossRef

Mazza E, Maccario M, Ramunni J, Gauna C, Bertagna A, Barberis AM et al (1999) Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels. J Endocrinol Invest 22:681–687PubMed

Morrison MF, Ten Have T, Freeman EW, Sammel MD, Grisso JA (2001) DHEA-S levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years. Biol Psychiatry 50(9):705–711PubMedCrossRef

Morsink LFJ, Vogelzangs N, Nicklas BJ, Beekman ATF, Satterfield S, Rubin SM et al (2007) Associations between sex steroid hormone levels and depressive symptoms in elderly men and women: results from the health ABC study. Psychoneuroendocrinology 32(8–10):874–883PubMedCrossRef

Paul IA, Skolnick P (2003) Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 1003:250–272PubMedCrossRef

Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385CrossRef

Randolph JF Jr, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N et al (2003) Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 88(4):1516–1522PubMedCrossRef

Rinaldi S, Peeters PH, Bezemer ID, Dossus L, Biessy C, Sacerdote C et al (2006) Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European prospective investigation into cancer and nutrition. Cancer Causes Control 17(8):1033–1043PubMedCrossRef

Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: Utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 92(2):405–413PubMedCrossRef

Schmidt PJ, Murphy JH, Haq N, Danaceau MA, St Clair L (2002) Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology 27(8):907–920PubMedCrossRef

Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS et al (2005) Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62(2):154–162PubMedCrossRef

Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W et al (2001) Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76(5):874–878PubMedCrossRef

Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV III, Hahn SR et al (1994) Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 272(22):1749–1756PubMedCrossRef

Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA 282(18):1737–1744PubMedCrossRef

Takebayashi M, Kagaya A, Uchitomi Y, Kugaya A, Muraoka M, Yokota N et al (1998) Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication. J Neural Transm 105(4–5):537–542PubMedCrossRef

Tichomirowa MA, Keck ME, Schneider HJ, Paez-Pereda M, Renner U, Holsboer F et al (2005) Endocrine disturbances in depression. J Endocrinol Investig 28(1):89–99

Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ et al (1997) Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 41(3):311–318PubMedCrossRef

Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L et al (1999) Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156(4):646–649PubMed

Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63(8):856–864PubMedCrossRef

Zeger SL, Liang KY, Albert PS (1988) Models for longitudinal data: a generalized estimating equation approach. Biometrics 44:1049–1060PubMedCrossRef

Title: Higher DHEA-S (dehydroepiandrosterone sulfate) levels are associated with depressive symptoms during the menopausal transition: results from the PENN Ovarian Aging Study
Authors: Mary Frances Morrison
Ellen W. Freeman
Hui Lin
Mary D. Sammel
Publication date: 01-10-2011
Publisher: Springer Vienna
Published in: Archives of Women's Mental Health / Issue 5/2011
Print ISSN: 1434-1816
Electronic ISSN: 1435-1102
DOI: https://doi.org/10.1007/s00737-011-0231-5

At a glance: The STEP trials

Springer Medicine

Higher DHEA-S (dehydroepiandrosterone sulfate) levels are associated with depressive symptoms during the menopausal transition: results from the PENN Ovarian Aging Study

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2011

Amy Wenzel: Anxiety in Childbearing Women—Diagnosis and treatment

Estrogen replacement therapy and cognitive functions in healthy postmenopausal women: a randomized trial

Posttraumatic stress disorder and trauma characteristics are correlates of premenstrual dysphoric disorder

Bio-socio-demographic factors associated with post-traumatic stress disorder in a sample of postpartum Brazilian women

Major depressive disorder during pregnancy and emotional attachment to the fetus

Salivary cortisol in pregnant women suffering from blood and injection phobia